Updated: 15 February 2019 to add section 17
Update 19 July 2019: Note that Scott Gottlieb, who features in this post, left the FDA on 5 April 2019 and joined the board of Pfizer on 27 June 2019: Ex-FDA boss joins Pfizer 83 days after leaving US drug regulator, Financial Times.
I have been following FDA Commissioner Scott Gottlieb on Twitter and was alarmed at the threat he issued to vapers and the vaping industry in response to recent trends in US adolescent vaping.
If this is his analysis, @SGottliebFDA hasn’t tried hard enough to understand what is – and is not – a material risk in these youth vaping numbers. Yet he appears willing to put millions of adult lives at risk by imposing regulatory overkill on a life-saving product for smokers. https://t.co/HB64pgtjRJ— Clive Bates (@Clive_Bates) January 13, 2019
I disagree with the FDA’s analysis of what is happening with adolescent vaping and also what should be done about it. So I need to put some flesh on the tweet above and examine some of FDA’s claims in more depth. Please dip to these talking points… it’s a long blog but I hope at least some of it will be illuminating.